Extremes of adipose tissue at diagnosis influences early response among pediatric HL.
У данной статьи нет абстракта.
Current evidence suggests that anti-CD30 CAR-T cell therapy is effective and safe in treating R/R cHL and is worth considering as a viable therapeutic option.